Neurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
Neurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
BMJ Case Rep. 2021 Jul 15;14(7):e242231. doi: 10.1136/bcr-2021-242231.
A 71-year-old woman presented to the emergency room with dysphonia, diplopia, dysphagia and generalised weakness since that day. Neurological examination revealed eye adduction limitation, ptosis, hypoactive reflexes and gait ataxia. Blood and cerebrospinal fluid analysis and brain CT were normal. Electromyography revealed a sensory axonal polyneuropathy. She was diagnosed with Miller-Fisher syndrome (MFS) and started on intravenous immunoglobulin. Two days after intravenous immunoglobulin treatment was completed, she developed a sustained hypertensive profile and presented a generalised tonic-clonic seizure. Brain MRI was suggestive of posterior reversible encephalopathy syndrome (PRES) and supportive treatment was implemented with progressive improvement. PRES may be a possible complication of MFS not only due to autonomic and inflammatory dysfunctions, but also as a consequence of its treatment. Patients with MFS should be maintained under close surveillance, especially in the first days and preferably in intermediate care units.
一位 71 岁女性因声嘶、复视、吞咽困难和全身无力于当日就诊于急诊室。神经系统检查显示眼球内收受限、上睑下垂、反射减弱和步态共济失调。血液和脑脊液分析及脑部 CT 均正常。肌电图显示感觉轴索性多发性神经病。她被诊断为米勒-费舍尔综合征(MFS)并开始接受静脉注射免疫球蛋白治疗。静脉注射免疫球蛋白治疗完成两天后,她出现持续高血压并出现全身强直阵挛性癫痫发作。脑部 MRI 提示为后部可逆性脑病综合征(PRES),并给予支持性治疗,症状逐渐改善。PRES 可能是 MFS 的一种并发症,不仅与自主和炎症功能障碍有关,而且可能是其治疗的结果。MFS 患者应密切监测,特别是在最初几天,最好在中级护理病房。